Guinea-Bissau halts planned hepatitis B newborn vaccine trial
A planned hepatitis B vaccine trial in newborns in Guinea-Bissau will not proceed, lead researcher Frederik Schaltz-Buchholzer said after the team concluded it had not received the necessary government approval. The project had already drawn backlash and a…
